Li addresses drug issue |

“More drugs for chronic diseases and common illnesses as well as more high-value medical consumables should be incorporated into the bulk-buying programme, as this is what people really care about”

Jan 14, 2022 (WiC 569)

Tweet

×Scan to share with WeChat
A A
Print this article

Premier Li Keqiang said that the government’s bulk-buying of drugs and medical consumables had saved more than Rmb260 billion ($40 billion) of medical insurance costs and patient expenditures last year. Li said the State Council has decided to increase the programme to lower drug costs further.

Sponsored by HSBC.

The Week in China website and the weekly magazine publications are owned and maintained by ChinTell Limited, Hong Kong. Neither HSBC nor any member of the HSBC group of companies ("HSBC") endorses the contents and/or is involved in selecting, creating or editing the contents of the Week in China website or the Week in China magazine. The views expressed in these publications are solely the views of ChinTell Limited and do not necessarily reflect the views or investment ideas of HSBC. No responsibility will therefore be assumed by HSBC for the contents of these publications or for the errors or omissions therein.

Sino-File

Li addresses drug issue

“More drugs for chronic diseases and common illnesses as well as more high-value medical consumables should be incorporated into the bulk-buying programme, as this is what people really care about”

More stories from this issue

Issue 611